C12Y 302/02023
Dna-formamidopyrimidine glycosylase
Official title: DNA-formamidopyrimidine glycosylase (3.2.2.23)
C12Y302/02023 (Dna-formamidopyrimidine glycosylase) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 5
- Assignees
- 4
- Inventors
- 18
- Latest grant
- 2 Aug 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Methods of Library Preparation30 May 2024US 2024/0175010 A1Illumina, Inc.
- Detection of recombinase polymerase amplification using dual-hapten probe14 Mar 2019US 2019/0078147 A1Alere San Diego, Inc.
- Method for Reducing Sequencing Errors Caused by DNA Fragmentation22 Feb 2018US 2018/0051341 A1New England Biolabs, Inc.
- Treatment of disease conditions via administration of dna repair enzyme30 Apr 2015US 2015/0118217 A1University of South Alabama
- Treatment of disease conditions via administration of dna repair enzyme12 May 2011US 2011/0110908 A1University of South Alabama
Most cited
By later US patents